Skip to main content

Table 4 Results of univariate Cox analyses in the prognostic risk stratification

From: Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone

Risk group

N

PFS

OS

Events

HR (95% CI)

p value

Events

HR (95% CI)

p value

Low

28

20

1

 

6

1

 

Intermediate

61

52

2.01 (1.19–1.37)

0.009

27

2.83 (1.16–6.87)

0.022

High

41

38

2.73 (1.58–4.72)

< 0.001

27

5.62 (2.30–13.78)

< 0.001

  1. CI: confidence interval; HR: hazard ratio; OS: overall survival; PFS: progression-free survival
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us